|
Alemtuzumab
|
Visite: 172
|
|
Altretamine
|
Visite: 354
|
|
Aminoglutetimide
|
Visite: 314
|
|
L'Acido 5-Aminolevulinico
|
Visite: 270
|
|
Idrossicarbamide
|
Visite: 175
|
|
Anastrozole
|
Visite: 340
|
|
Arsenico Triossido Di
|
Visite: 304
|
|
Asparaginasi
|
Visite: 294
|
|
Bevacizumab
|
Visite: 185
|
|
Bexarotene
|
Visite: 336
|
|
Bleomicina
|
Visite: 329
|
|
Busulfan
|
Visite: 296
|
|
Capecitabina
|
Visite: 312
|
|
Carboplatino
|
Visite: 361
|
|
Carmustina
|
Visite: 356
|
|
Cetuximab
|
Visite: 215
|
|
Ciclofosfamide
|
Visite: 197
|
|
Cisplatino
|
Visite: 210
|
|
La citarabina
|
Visite: 183
|
|
Cladribina
|
Visite: 205
|
|
Chlorambucil
|
Visite: 313
|
|
Chlormethinum
|
Visite: 325
|
|
Dacarbazina
|
Visite: 162
|
|
Dactinomicina
|
Visite: 217
|
|
Daunorubicina
|
Visite: 166
|
|
Docetaxel
|
Visite: 166
|
|
Doxorubicina
|
Visite: 338
|
|
Epirubucin
|
Visite: 159
|
|
Erlotinib
|
Visite: 168
|
|
Etoposide
|
Visite: 196
|
|
Exemestano
|
Visite: 227
|
|
Fluorouracile Topico Soluzione
|
Visite: 149
|
|
Fluorouracile
|
Visite: 222
|
|
Gemcitabina
|
Visite: 154
|
|
Idarubicina-Hcl
|
Visite: 196
|
|
Ifosfamide
|
Visite: 149
|
|
Melfalan
|
Visite: 151
|
|
Mercaptopurina
|
Visite: 194
|
|
Methotrexate
|
Visite: 247
|
|
Mitomicina
|
Visite: 250
|
|
Mitoxantrone
|
Visite: 156
|
|
Oxaliplatino
|
Visite: 135
|
|
Paclitaxel
|
Visite: 189
|
|
Pentostatina
|
Visite: 184
|
|
Procarbazina
|
Visite: 160
|
|
Rituximab
|
Visite: 209
|
|
Teniposide
|
Visite: 156
|
|
Tioguanina
|
Visite: 144
|
|
Tiotepa
|
Visite: 150
|
|
Trastuzumab
|
Visite: 188
|
|
Tretinoin Orale
|
Visite: 190
|
|
Vinblastina
|
Visite: 162
|
|
Vincristina
|
Visite: 154
|
|
Vinorelbine Tartrate
|
Visite: 175
|
|
Everolimus
|
Visite: 171
|
|
Imatinib Mesilato
|
Visite: 166
|
|
Nilotinib
|
Visite: 205
|
|
Dasatinib
|
Visite: 168
|
|
Pazopanib
|
Visite: 144
|
|
Ipilimumab
|
Visite: 145
|
|
Nivolumab
|
Visite: 194
|
|
Brentuximab Vedotin
|
Visite: 175
|